Kevin W Garey

Texas A&M Health Science Center

NIH Rank #13733
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#13,733
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.1M across 4 grants · National rank #13733.

Top grants by award amount

Kevin W Garey's NIH grant portfolio, ranked by award amount.

  • 5R01AI139261-06R01
    Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
    $768.1K
    award amount
  • 3R01AI139261-06S1R01
    Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
    $183.8K
    award amount
  • 1R03AI178015-01A1R03
    Vancomycin Susceptibility Measures to Evaluate C. difficile infection Outcomes
    $77.9K
    award amount
  • 3R01AI139261-06S2R01
    Diversity Supplement: Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection
    $52.4K
    award amount

Affiliations

Institutions that have administered grants for Kevin W Garey.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Texas A&M Health Science Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Multi-Institutional Research
    Awards at 2 institutions